CLOVIS ONCOLOGY INC (NASDAQ:CLVS)

Bull and Bear

Top Analyst Upgrades and Downgrades: BofA, NetApp, Stratasys, Symantec, Wells Fargo and More

The stock market was unable to hold new all-time highs, and investors are looking for both gains and protection in the next sell-off. 24/7 Wall St. reviews many analyst calls ...
Read Full Story »
JPMorgan_logo

J.P. Morgan Top Biotechnology Stocks to Buy for 2014

Biotechnology was an incredible performer in 2013, outperforming the S&P 500 by a stunning 36%. The analysts at J.P. Morgan think that the huge outperformance may lessen but can stay ...
Read Full Story »

Today’s Market Winners and Losers

The stock market is down Monday, with the Dow Jones Industrial Average down 0.08%, the Nasdaq down 0.02% and the S&P 500 down 0.01%. Today's winners include two companies getting ...
Read Full Story »

Mid-day Movers (VRS, STLY, MWA, DNDN, CLVS)

Shortly after noon ET today, all three major US stock indexes have posted solid gains, with the DJIA up about 54 points at around12,892, the Nasdaq up about 27 points ...
Read Full Story »

Best Recent IPO Class: Up 50% Or More (KORS, INVN, IMPV, CLVS, GWRE, MFRM, JIVE, LPI)

IPO Fever has not really caught on in a major way yet in 2012.  The Facebook halo-effect did bring a pop and private equity firms are still seeming to hold ...
Read Full Story »